Paradigm Capital Management Inc’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,000
Closed -$176K 136
2023
Q4
$176K Buy
+20,000
New +$176K 0.01% 128